Caltech Researcher Granted $500,000 Career Award

PASADENA, Calif.- As a young medical student, Matthew Porteus recalls his frustration when admitting his first patient with chronic pain caused by sickle-cell anemia. There was little medicine could do to help her in a sustained and meaningful way. The experience influenced his decision to study the basic mechanisms of "gene targeting," one possible way to cure such diseases, which are caused by a single mutation in a cell. Now Porteus will be assisted in his studies thanks to a grant from the Burroughs Wellcome Fund.

The Career Award in the Biomedical Sciences is a five-year, $500,000 grant that consists of two parts – a two-year postdoctoral portion, and a three-year faculty portion. The program is intended to develop biomedical researchers early in their careers as they make the transition to becoming independent investigators.

Porteus is currently a postdoctoral researcher in the lab of Caltech president David Baltimore. Porteus's work is focused on developing techniques to increase the efficiency and specificity of gene targeting in human somatic cells. Gene targeting is a technique in which a gene is introduced into a cell to replace a specific gene that's been damaged.

Porteus notes there are now scores of diseases that are caused by mutations in single genes. Sickle-cell anemia, for example, is caused by a single mutation in the protein that carries oxygen in the blood. Cystic fibrosis, in which there is a small mutation in a channel that regulates salt and water flux into cells, is another.

Gene targeting is one promising approach to curing such diseases. Researchers like Porteus can introduce genetic change into a cell by creating subtle differences between the introduced gene and the target gene. Gene targeting is now widely used in the generation of "knockout" mice, in which genes are "knocked out" or disrupted, then replaced by genes from other organisms that are inserted into a particular genetic location. But gene targeting has had an extremely low success rate in human somatic cells. Porteus's work is focused on understanding the mechanism and regulation of gene targeting, with the goal of developing it as a technique for gene correction therapy.

To study gene targeting, Porteus and his colleagues have developed a system in which they can correct a mutation in a specific gene called GFP. From this, they have established several of the key parameters that regulate gene targeting in human somatic cells. The first major parameter is the role of DNA double-stranded breaks. As the name implies, these are a form of DNA damage in which both strands of the DNA molecule are broken. Porteus confirmed what others have shown, that the presence of a DNA double-stranded break in the target gene can stimulate the process of gene targeting by over 10,000-fold; that increases the success rate from one in a million to 3 to 5 percent. Porteus is currently working on ways to generate double-stranded breaks in a target gene.

The second major parameter is the role of random integration. When a gene is introduced into a cell it can either be integrated into the genome of the cell in a random fashion, or replace a specific gene. In human somatic cells the relative rate of gene targeting is very low, in part because the random integration rate is high. Porteus is working to understand the factors behind this, since, in other cell types, he's found that the relative rate of gene targeting is high because random integration is low. Besides studying the factors that affect the rate of random integration, he is developing techniques to block it as well.

Porteus believes that such focused study will eventually lead to gene targeting becoming a tool for gene correction therapy, and for a potential cure for people suffering from diseases that are caused by mutations in single genes.

The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the medical sciences by supporting research and other scientific and educational activities. Within this broad mandate, BWF's general strategy is to help scientists early in their careers develop as independent investigators, and to support investigators who are working in or entering fields in the basic medical sciences that are undervalued or in need of encouragement.-

Exclude from News Hub: 

Brain oscillations compress odor representations as signals pass through olfactory networks

Most natural smells are complex blends of many individual chemicals. Freshly ground coffee, for example, contains about 300 individual volatile components. A typical perfume also contains tens of ingredients, although the recipes are tightly locked in secret vaults.

The percepts that such complex blends evoke in us are, however, astonishingly singular: ground coffee smells like coffee, not like a hopeless mess of hundreds of ingredients; Gio or Allure also have unique signatures (often associated with other memories). This contrast between a physical object's complexity and the uniqueness of how we perceive it is the expression of what brains do best: "bind" features together into highly recognizable patterns.

This is as true of smell as it is for the other senses: a person can immediately recognize his mother's face or voice. How this useful and effortless compression of information is accomplished by the brain is one of the deep mysteries of neuroscience. In addition, understanding the mechanisms of compression would help in the design of computerized pattern recognizers (e.g., face recognition devices), a very difficult task with many important applications.

This issue is the subject of new research from neurobiologist Gilles Laurent and his team in the California Institute of Technology's computation and neural systems program. In a paper appearing in the July 19 issue of the journal Science, the Laurent team reports that the complicated wiring in grasshoppers between the antennal lobe (the insect analog of the olfactory bulb in humans) and the mushroom body (the insect analog of the olfactory cortex) is arranged and functions in such a way that highly detailed information in the former is bound or compressed for future memory use in the latter.

To better explain the details of their discovery, it's probably best to first explain the organs of smell in grasshoppers. The first area associated with smell are the receptor cells that are the front line of cells coming into contact with the chemical elements of a smell. Information from the receptor neurons converge in the antenna lobe, which, in grasshoppers, comprises about 1,000 individual neurons. The signal then goes to the mushroom body, which comprises about 50,000 neurons.

By intricately wiring glass, silicon, and platinum wire electrode arrays into the brains of hundreds of grasshoppers to record activity from their neurons, then exposing the insects to a variety of smells, the Laurent team has demonstrated some of the fine details of this wiring and its consequences for odor encoding.

When a specific odor is detected by a grasshopper, the antennal lobe neurons, wired to the peripheral detector array, start a complicated "dance" that engages about half of its 1,000 neurons. Each individual odor evokes a different dance or spatio-temporal pattern that involves partially overlapping subsets of neurons activated at varying times. Hence, determining from these patterns the odor's identity is a very difficult task; it requires that an observer decode the details of the dance, identify the correlations between the activities of all the neurons, and put all this back together into a coherent whole. Said differently, the informative value of any antennal lobe neuron in isolation is close to zero: valuable information comes only from deciphering the message carried by the population.

Population decoding is precisely what is done by the downstream neurons (called Kenyon cells, in the mushroom body). Those neurons, using a complicated combination of wiring, biophysical properties, brain oscillations, and loops of inhibition, manage to compress the information carried by many antennal lobe neurons into highly specific and sparse signals. Thus, individual Kenyon cells are silent most of the time and produce a signal only in response to very specific odors. The signals from these neurons, when given out, are thus highly informative, Laurent says.

"If you observe Kenyon cell No. 2,976 and see that it produced one single pulse, you can be pretty confident that the animal has just detected a certain odor mixture and not another," he explains. Each Kenyon cell thus has a very limited, but highly specific repertoire of "preferred stimuli."

At the same time, this compression eliminates much of the information about the individual chemical elements that make up an odor. "Knowing that Kenyon cell No. 2,976 fired may tell me that the (grasshopper) just smelled a cherry blend, but it tells me nothing about the chemical composition of that smell."

This may explain why these individual elements cannot be perceived; the encoding and decoding of an odor as a whole (cherry or Gio) is done at a cost: detail is lost. The advantage, however, is that the storage and retrieval of this odor's representation has become very simple, fast, and manageable: Each odor, however complex, is now represented by very few, highly specific neurons. Because the mushroom body has many neurons (and our olfactory cortex has even more), a huge number of such memories can be stored.

"There are many reasons to think that odor perception may work in similar ways in vertebrates, including humans," Laurent says, explaining that the antennal lobe in insects, including flies, is very similar to the mammalian olfactory bulb, except that it possesses many fewer cells; and that the mushroom body is likewise similar to the human olfactory cortex.

"In the case of humans as well as animals, the brain is not doing analytical chemistry by pulling out individual components," he says. "Instead, you have a very good memory for odors, however complex, even though you lose information about details. After all, throwing away information is one of the most important things that brains do, but it must be done carefully.

"In olfaction as well as in vision and the other senses, the brain must represent and memorize a huge number of complicated patterns. One should expect that evolution has found an optimal way of solving this task. Our work provides the beginnings of a solution, although whether it applies to other senses remains to be seen."

In addition to Laurent, the other authors of the study, all members of Caltech's Division of Biology, are Javier Perez-Orive, Ofer Mazor, Glenn C. Turner, Stijn Cassenaer, and Rachel I. Wilson.

The paper is available online at

Contact: Robert Tindol (626) 395-3631


New Clues to the Processing of Memories

PASADENA, Calif.- Quick! Memorize this sentence: The temporoammonic (TA) pathway is a entorhinal cortex (EC) input that consists of axons from layer III EC neurons that make synaptic contacts on the distal dendrites of CA1 neurons.

If by chance you can't memorize this, say two researchers from the California Institute of Technology, it may be due to this very TA pathway that is modulating what your brain remembers.

In another clue toward understanding the processing of memories, graduate student Miguel Remondes and Erin M. Schuman, an associate professor of biology at Caltech and an assistant investigator of the Howard Hughes Medical Institute, have now gleaned two possible roles for the TA pathway that until now were not known. The research is reported in the April 18 issue of the journal Nature.

Using rat hippocampal slices, they've found that this pathway may be part of the brain's decision-making process about whether to keep a particular input and form a memory, or reject it.

Input from the senses—an odor, a sight, or a sound, say, is first received by the brain's cortex. Then, via a specific pathway of nerve fibers long known to scientists, the signals are sent on to the hippocampus. That organ processes the signals, then sends them back to the cortex, probably for long-term storage.

Scientists have also known about the TA pathway, but not its function. Now Remondes and Schuman report that the TA pathway may serve as a memory gatekeeper that can either enhance or diminish the signals of the specific set of neurons that form a memory. Further, they've shown that this pathway may also provide the hippocampus with the information it needs to form so-called place-selective cells; that is, cells that help animals to know where they are in their environments.

The hippocampal formation comprises several structures in the brain and includes the seahorse-shaped hippocampus and a second organ called the dentate gyrus. The formation is involved in saving and retrieving long-term memories. Scientists divide the hippocampus into four divisions, from CA1 to CA4. CA1 and CA3 play major roles in processing memory.

In their quest to understand how communication between neurons contributes to memory, scientists have focused on the "trisynaptic circuit." When input from the senses reaches the cortex, it's sent on to the dentate gyrus, then on to the hippocampus. There, the signals are serially processed by synapses in areas CA3 and CA1 of the hippocampus (synapses are gaps between two neurons that function as the site of information transfer from one neuron to another). Finally, the hippocampus sends a signal back to the cortex. That's the trisynaptic circuit.

Remondes and Schuman found that the TA pathway also sends signals. But its input comes from a different part of the cortex and goes directly to the CA1 section of the hippocampus. The TA pathway reacts depending on how close in time the synaptic signals from the hippocampus are from the original signal sent by the trisynaptic circuit. If it is close, within 40 milliseconds, the TA pathway will act as a signal (and thus a memory) enhancer; that is, it will allocate a stronger synaptic signal from the hippocampus. If it is far, more than 400 milliseconds, it will inhibit the signal.

"So the brain sends the information to the hippocampus," says Remondes, "and instead of just collecting the result of its activity, the hippocampus may very well perform 'quality control' on the potential memory. And it may be doing this by using the direct cortical input from the TA pathway." Perhaps, then, this is a further clue to how memories are stored—or forgotten.

In addition, although the scientists have not done any specific spatial memory experiments, their work may have relevance to how the brain forms place-selective cells. Since other studies previously established that the trisynaptic circuit is not necessary for spatial memory, some of the important information entering the hippocampus may actually be provided by the TA pathway.

"The TA pathway has been briefly described in the past, but not really acknowledged as a 'player' in the memory debate," says Remondes. "Hopefully, these findings will bring new insight into how we form, or don't form, memories."

Exclude from News Hub: 

Gaining a Better Understanding of the Brain

PASADENA, Calif. — A panel of experts who conduct a wide range of brain research will come together for California Institute of Technology's annual Biology Forum, "Gray Matters: Perception, Intention, Memory, and Dysfunction in the Brain," April 25 at 8 p.m. in Beckman Auditorium, 332 S. Michigan Ave, Pasadena. The event is free and open to the public.

The speakers for the program, which is sponsored by Caltech and Huntington Memorial Hospital and co-sponsored by the San Gabriel Valley Newspaper Group, will discuss topics as diverse as the dynamics of smell, moving robotic limbs using brain signals, and pinpointing and excising the spot in the brain where epilepsy seizures occur.

"Our speakers exemplify the world-class work that is being done on the brain right here in Pasadena," says Paul Patterson, biology professor and Biology Forum coordinator. Three of the four speakers are Caltech faculty and one is a Huntington Hospital neurosurgeon.

The speakers are:

Richard Andersen, James G. Boswell Professor of Neuroscience at Caltech. Andersen and his colleagues are beginning to decipher neuron firing patterns in the visuomotor part of the brain preceding arm movement. Using this code they can now predict where the arm will be moved. The eventual goal of this research is to develop a neural prosthesis that records this intended-movement signal from paralyzed patients, enabling them to operate a robot limb or other external devices.

Gilles Laurent, professor of biology and computation and neural systems at Caltech. Laurent studies neural coding in the brain. He focuses on the dynamics of neuronal circuits, brain oscillations, and the sense of smell, in insects, fish, and rodents. His laboratory studies the general problem of olfactory representations: how is an odor represented by brain circuits? What are the neuronal elements of the memory of a smell? What do brain circuits do to optimize those representations?

Adam Mamelak, neurosurgical director of the Epilepsy and Brain Mapping Program at Huntington Memorial Hospital, and associate professor of neurosurgery at City of Hope Cancer Center. The Huntington Brain Mapping Program is one of a handful of comprehensive epilepsy centers in the country. Through the program, patients' seizures and normal brain functions are mapped, the source of seizures is pinpointed, and the damaged portion of the brain is excised. It provides the most advanced and successful seizure evaluation and treatment available today.

Steven Quartz, assistant professor of philosophy at Caltech. Quartz uses experimental and theoretical methods from neuroscience to study traditional problems of mind, ranging from the formal learning properties of neurally constrained developing systems to the nature of moral decision-making.

The moderator of the program will be Robert Lee Hotz, a Pulitzer Prize-winning science writer with the Los Angeles Times.

For more information, call (626) 395-4652 or toll-free 1-888-222-5832. Persons with disabilities can call (626) 395-4688 (voice) or (626) 395-3700 (TDD) weekdays, 9 a.m. to 4 p.m.

CONTACT: Jill Perry, Media Relations Director (626) 395-3226

Visit the Caltech media relations web site:


Caltech and Purdue scientists determinestructure of the Dengue fever virus

Scientists at the California Institute of Technology and Purdue University have determined the fine-detail structure of the virus that causes dengue fever. This advance could lead to newer and more focused strategies for devising a vaccine to protect the world against a viral illness that causes 20,000 deaths each year.

Reporting in the March 8 issue of the journal Cell, Caltech biology professor James H. Strauss, lead author Richard J. Kuhn of Purdue (a former postdoctoral scholar in Strauss's lab), and Michael G. Rossman and Timothy S. Baker, both of Purdue, describe the structure of the virus they obtained with a cryoelectron microscope. The detailed electron-density map shows the inner RNA core of the virus as well as the other spherical layers that cover it. At the surface is the glycoprotein scaffolding thought to allow the virus to interact with the receptor and invade a host cell.

This is the first time the structure of one of the flaviviruses has been described, Strauss says. The flaviviruses are a class of viruses that include the yellow fever, West Nile, tick-borne encephalitis, and Japanese encephalitis viruses. All are enclosed with a glycoprotein outer layer that includes minor projections out of the lipid layer due to the geometry of the scaffolding.

"Most viruses that cause serious illness are enveloped, including influenza, hantaviruses, West Nile virus, smallpox, and herpes—though not polio," Strauss says.

The surprise for the researchers was the unusual manner in which the glycoproteins are arranged. Details from the Caltech and Purdue computer-generated images show a highly variegated structure of glycoprotein molecules that are evenly dispersed, but with a surprisingly complicated pattern.

"It's symmetrical, but not with the obvious symmetry of most symmetric viruses," Strauss explains. "This was not an expected result."

Strauss says it's still unclear what the odd symmetry will ultimately mean for future research aimed at controlling the disease, because the precise function of the different structural domains of the glycoproteins are still not known. Those that have been false-colored blue in the image are the domain of glycoproteins thought to be involved in receptor binding—and thus responsible for the virus's entry into a cell. The glycoprotein structures coded yellow are an elongated domain thought to be responsible for holding the scaffolding together; and the ones coded red have a function that is not yet known.

But a more detailed view of these structures is the beginning of a more informed strategy for a focused medical or pharmaceutical attack, Strauss says. "You can think of the protease inhibitors for HIV. Those in large part came from knowing the structure of the HIV enzymes you were trying to interfere with."

Thus, the new work could lead to drugs that will bind to the virus to prevent it from entering the cell, or perhaps from reassembling once it is already inside the cell.

Dengue fever is a mosquito-spread disease that has been known for centuries, but was first isolated in the 1940s after it became a significant health concern for American forces in the Pacific theater. A worldwide problem, the disease is found throughout Latin America, the Caribbeans, Southeast Asia, and India, and is currently at epidemic levels in Hawaii.

Especially virulent is the closely related dengue hemorrhagic fever, which is responsible for most of the deaths. The disease is a leading cause of infant mortality in Thailand, where there is an especially vigorous program to find an effective vaccine.

More information can be found on the Center for Disease Control Web site at

Contact: Robert Tindol (626) 395-3631


Caltech Scientists Block Effect of Huntington Disease Protein in Cultured Cells

PASADENA, Calif.— Huntington's disease is a cruel disorder, destroying nerve cells in the brain that, over time, rob an individual of the ability to walk, talk, and eat. As yet, there is no cure or effective treatment for this hereditary disorder. The end result, then, is death, caused by such complications as infection or heart failure.

Now scientists at the California Institute of Technology have come one step closer to understanding how Huntington's disease develops and how it can be stopped. In a paper to be published in the January 22 issue of the Proceedings of the National Academy of Sciences, Paul H. Patterson, a Caltech professor of biology, postdoctoral scholar Ali Khoshnan, and research assistant Jan Ko have blocked the effects of the disease in cultured cells using antibodies.

Huntington's disease (HD) is caused by a mutation in the protein huntingtin (htt), specifically by the expansion of a site on the protein called polyQ. Such sites induce the production of antibodies that bind with a particular site, normally to kill the antigen. Khoshnan and his colleagues made an antibody that binds to the polyQ site, along with another antibody that binds to a different site, called polyP. The idea was to block either of these sites and see whether the toxic effects of mutant htt, which kills nerve cells in the brain, could be blocked.

"We knew that the polyQ site was critical because when it is expanded by mutation it causes HD," says Patterson." "It was also known that the polyP site on htt might be important for interfering with the functions of other proteins." The investigators produced a modified version of the antibodies that would allow them to be produced inside cells that also carry the toxic mutant htt. They found a key result: when the antibody against the polyP site is produced by cells carrying the mutant htt, the cells are rescued. That is, they are unaffected by the toxic HD protein. In striking contrast, when cells carrying the toxic htt are induced to produce the antibody against the polyQ site, the toxicity of htt is enhanced and the cells die even faster.

Khoshnan and coworkers suggest that the surprising result with the polyQ antibody may be due to the antibody stabilizing a shape of the mutant htt protein in its most deadly form. Most important, though, says Patterson, is that the rescue of the cells that produce the polyP antibody may indicate this is the site of the toxic htt in which the actual killing of cells takes place, and that covering it up with an antibody saves the cell. "Or, an alternative interpretation is that the binding of the antibody preserves the protein in a non-toxic shape," he says.

The researchers have two goals in mind with their work: elucidating the mechanism of neuronal death caused by mutant htt, and devising molecular strategies for blocking its toxic effects.

To arrive at their results, the scientists first developed eight monoclonal antibodies (mAbs), finding the three that either inhibited or exacerbated the toxicity of the mutant Htt protein. They next cloned the antigen-binding "domains" of the three; that is, the portion of the mAbs that does the actual binding. Finally, they caused these domains to be produced inside cells that were also making the mutant htt.

"Potentially, this knowledge could be useful in designing a therapeutic drug, one that covers up that part of the mutant protein that kills healthy cells," says Patterson. "The next stage of the work will be to deliver this antibody into the brains of mice that carry the human mutant gene and that have developed motor symptoms that are related to the disease. We want to see if this antibody can rescue these mice, even after they show signs of the disease. These experiments are, however, just beginning."

Exclude from News Hub: 

Caltech biologists invent newer, better methodfor making transgenic animals

Using specially prepared HIV-derived viruses stripped of their disease-causing potential, California Institute of Technology biologist David Baltimore and his team have invented a new method of introducing foreign DNA into animals that could have wide-ranging applications in biotechnology and experimental biology.

The Baltimore team reports, on today's Science Express Web site, on their study of single-cell mouse embryos that have been virally infected in a manner that leaves a new gene from a jellyfish permanently deposited into their genomes. The mice, after they have been carried to term, carry at least one copy of the gene in 80 percent of the cases, and 90 percent of these show high levels of the jellyfish protein. Further, the study shows that the offspring of the mice inherit the genes and make the new protein. Thus the method makes transgenic mice that have new genetic potential.

According to Baltimore, who is president of Caltech, the use of the HIV-like viruses could prove far superior to the current method of producing transgenic animals by pronuclear injection.

"It's surprising how well it works," says Baltimore, whose Nobel Prize-winning research on the genetic mechanisms of viruses 30 years ago is central to the new technique. "This technique is much easier and more efficient than the procedure now commonly in use, and the results suggest that it can be used to generate other transgenic animal species."

The technique exploits features of HIV-like viruses known as lentiviruses, which can infect both dividing and non-dividing cells, as gene delivery vehicles. Unlike HIV, the lentivirus is rendered incapable of causing AIDS. The lentivirus carries new genes into the cell's existing genome. In this case, newly fertilized mouse eggs were engineered to carry the green fluorescent protein (GFP) derived from jellyfish.

Baltimore and his team developed two ways of introducing the lentivirus into cells: microinjection of virus under the layer that protects recently fertilized eggs, or incubation of denuded fertilized eggs in a concentrated solution of the virus. The latter method is easier, although less efficient.

The transgenic mice, once they are born, carry a protein marker in all body tissues that make them glow green under a fluorescent light. This trait is genetic because the trait is a permanent feature of the animal's genome, and thus is carried throughout life and is inheritable by offspring. The term "transgene" refers to the fact that the new gene has been transferred.

Transgenics holds promise to biotechnology and experimental biology because the techniques can be used to "engineer" new, desirable traits in plants and animals, provided the trait can be identified and localized in another organism's genome. A transgenic cow, for example, might be engineered to produce milk containing therapeutic human proteins, or a transgenic chicken might produce eggs low in cholesterol.

In experimental biology, transgenics are valuable laboratory animals for fundamental research. A cat with an altered visual system, for example, might better accommodate fundamental studies of the nature of vision.

According to Baltimore, the procedure works on rats as well as mice. This is a huge advantage to experimentalists because of the number of laboratory applications in which rats are preferable, he says.


Sound alters the activity of visual areas in the human brain,Caltech research reveals

Scientists at the California Institute of Technology have discovered that hearing can significantly change visual perception, and that the influence of hearing on visual perception occurs at an early perceptual level rather than at a higher cognitive level.

Ladan Shams, a Caltech postdoctoral researcher, and Shinsuke Shimojo, a professor of computation and neural systems at Caltech report that visual signals are influenced significantly by sounds at early cortical levels that have been believed to be "vision specific."

The team's initial behavioral finding was that when an observer is shown one flash of light accompanied by two beeps, the visual system is tricked so that the observer sees two flashes instead of one. In the new study, 13 healthy volunteers were asked to observe the stimuli on a computer screen and judge the number of flashes they saw on the screen.

While the participants performed the task, their brains' electric potentials were recorded from three electrodes positioned in the back of the scalp, where the early visual areas are located.

The researchers found that when the participants perceived the illusion—in other words, when sound changed the visual perception—the activity in the visual areas was modified. Furthermore, the change in activity was similar to that induced by an additional physical flash.

This suggests that the second flash, which is nothing but an illusion and is not due to a visual stimulus but rather caused by sound, invokes activity in the visual areas very similar to that which would be caused by a physical second flash. In short, sound induces a similar effect in this area of the brain to a visual stimulus.

The goal of this study was to get an understanding of how this alteration of vision by sound occurs in the brain. More specifically, the researchers asked whether the change in visual perception is caused by a change in the higher-level areas of the brain that are known to combine information from multiple senses, or whether it is a change that directly affects the activity of the areas that are believed to be exclusively involved in processing visual information.

The main result of the study was that the early visual cortical responses were modulated by accompanied sounds under conditions where the observers experienced the double-flash illusion. This suggests that the activity of the "visual" areas in the brain is affected by sound.

These findings challenge two traditional perspectives on how the brain processes sensory information. The first assumption is that humans are visual animals; vision is the dominant modality and hence not malleable by information from other modalities. Another general belief is that the information from different modalities is processed in the brain in parallel and separate paths.

The findings show that the visual information is affected by the auditory signals while being processed in the "modality-specific" visual pathway. These findings, together with earlier results in other modalities, suggest a paradigm of sensory processing that is more intertwined than segregated.

"The findings have an important implication for the new studies of human perception," says Shimojo. The overwhelming majority of studies in the field of perception have concerned themselves with one modality alone (based on the assumption of modality segregation).

This study, together with other studies indicating vigorous early plasticity and interactions across sensory modalities, is also very encouraging for applications such as sensory aids for children suffering from blindness or dyslexia, for educational applications, for man-made interfaces, and for media and information technology.

A report on this study will appear in the December issue of the journal NeuroReport. Ladan Shams is lead author of the paper.

Contact: Robert Tindol (626) 395-3631


Caltech biologist Barbara Woldnamed Beckman Institute director

Caltech biology professor Barbara Wold has been appointed director of the Beckman Institute, President David Baltimore announced today. She succeeds founding director Harry Gray, who will return to full-time professorial duties after 15 years at the institute's helm.

Wold, who specializes in embryonic development and regeneration in vertebrates, will lead the Beckman Institute in its continuing goal of building a research interface between chemistry and biology, Baltimore said.

"Professor Wold was chosen to be the second leader of this unique Caltech institution after careful consideration of the pool of candidates," Baltimore said. "We would also like to take this opportunity to thank Harry Gray, who over the past 15 years has provided his talents and energy in formulating and implementing the vision of the Beckman Institute and its exciting program of science and technology."

The Beckman Institute was opened in 1989 in a 160,000-square-foot building on the west end of campus. Made possible with an initial $50-million commitment and challenge from the Arnold and Mabel Beckman Foundation in 1986, the institute provides space for interdisciplinary work in endeavors such as advanced imaging, methods for synthesizing and sequencing genes and proteins, laser spectroscopy and X-ray diffraction, synthesis and characterization of novel organic and inorganic materials, and advanced mass spectroscopic methods for characterization of large biomolecules.

Wold has been a professor of biology at Caltech since 1981. She earned her bachelor's degree in 1973 from Arizona State, her doctorate from Caltech in molecular developmental biology, and did postdoctoral research at Columbia College of Physicians and Surgeons.

Wold has been active in national and international science policy concerned with the Human Genome Project, advising the National Institutes of Health and the Department of Energy programs in genomics.

She is the author of some 60 papers in professional journals.


Caltech completes $111 million fundraising effort for the biological sciences

The California Institute of Technology has successfully completed a $111 million fundraising effort begun in 1998 to expand the biological sciences. The $111 million exceeds the original $100 million goal.

Funds raised during the Biological Sciences Initiative (BSI) will make possible a new building on the Pasadena campus, new professorships and fellowships, new faculty appointments, and a wide range of new research programs.

In commenting on the successful conclusion of the BSI, Caltech President David Baltimore said, "Caltech's biological heritage and traditional interdisciplinary strength give us a powerful advantage when addressing fundamental biological questions. The Institute's faculty have already made creative use of early BSI planning and gifts to create unique research and teaching opportunities that bring the perspective of fields such as geology, chemistry, computation, physics, philosophy, and engineering to bear on complex biological questions.

"The announcement this summer of the mapping of the human genome provided unequivocal evidence that modern biology has evolved into a science of information," Baltimore continued. "As noteworthy a milestone as that accomplishment will be in the annals of scientific history, the completion of the Human Genome Project really just provides scientists with a new tool—not with solutions. The gifts our donors made to the BSI will provide our talented scientists, engineers, and social scientists with critical resources to move beyond the genomic information to explore the basic questions of life and disease.

"The phenomenal success of the BSI reflects the foresight of many individuals in supporting Caltech's important work in the biological sciences," Baltimore added. "On behalf of the entire Caltech community, I wish to express my appreciation to the donors to the campaign for enabling this work to move forward and to the dedicated and enthusiastic members of the BSI Gift Committee who guaranteed the success of the Biological Sciences Initiative."

This research will result in new drugs and therapies to address diseases such as cancer and AIDS, and will also lead to a deeper understanding of how organisms develop and why they sometimes develop anomalies, as well as an understanding of the biological basis of higher-level brain functions such as consciousness and cognition.

Cochairs for the BSI were Caltech alumnus Ben Rosen (who has since been named chairman of the board of trustees) and senior trustee Camilla Frost. The campaign was planned and led by a special committee comprising trustees, alumni, faculty, and other friends of the Institute.

"Speaking for the committee, we are extremely pleased with the result of the campaign, and we want to thank all of Caltech's friends for supporting this great effort," said Frost, who contributed $5 million toward construction of the Broad Center, the building that will be made possible by the campaign.

"Caltech's supporters have always been extremely generous," added Rosen, who contributed $5 million and thereby single-handedly met the campaign's goal for endowed graduate fellowships.

"In the case of the BSI, I think our friends realized that it was particularly important to support the Institute's programs in the biological sciences, given the opportunity to make important discoveries that will improve the human condition," Rosen said.

The physical centerpiece of the new research efforts will be the Broad Center for the Biological Sciences, named for Caltech trustee and Los Angeles business and civic leader Eli Broad and his wife, Edythe. The Broads provided $23 million—the lead gift—for the building, which is currently under construction and is projected to open for research occupancy next summer. The building is designed by world-renowned architect James Freed, who also designed the acclaimed U.S. Holocaust Memorial Museum in Washington, D.C.

The Broad Center will house about a dozen research groups working in such areas as structural, behavioral, and computational biology, and will also contain shared facilities for electron microscopy and magnetic resonance imaging. Additional funding for the building's construction and equipment has come from the estate of William Hacker, Caltech class of 1931, which provided $8 million in capital funds as well as $1.4 million in discretionary funds for the chair of the Division of Biology.

Eight new professorships were endowed through the campaign. Trustee Donald Bren contributed $10 million through the Donald L. Bren Foundation to support new faculty as Bren Scholars and eventually endow five Bren Professorships.

More than 5,500 Caltech alumni participated in the BSI by responding to a challenge from Ron and Maxine Linde, in which the Lindes agreed to match new and increased gifts toward the naming of the Ronald and Maxine Linde/Caltech Alumni Laboratories on the ground floor of the Broad Center.

Also, Caltech received $5 million from the late William and Georgina Gimbel, to be designated for the William T. Gimbel Discovery Fund in Neuroscience. The Keck Foundation, too, provided a $5 million Discovery Fund.

Through the BSI, Caltech has already made several new appointments of young faculty members whose interests are indicative of the interdisciplinary nature of the initiative. For example, David Chan, assistant professor of biology, uses cell biological, biophysical, and genetic approaches to study how membrane-bound systems like organelles and viruses fuse under certain circumstances.

In particular, Chan is interested in understanding the fusion mechanism of mitochondria, organelles important for energy production and cell death. In addition, he studies how the human immunodeficiency virus (HIV), the agent of the disease AIDS, enters human cells by fusing with the cell membrane.

Dianne Newman, the Clare Boothe Luce Assistant Professor of Geobiology and Environmental Engineering Science, is leading a project to investigate how microorganisms and Earth's near-surface environments have interacted over billions of years. Her project integrates molecular microbiology with geochemistry and field geology to try to identify chemical signatures of early life in the geological record.

"The biological sciences today present an intellectual challenge that is changing the environment at Caltech," said Mel Simon, the former chair of the Caltech Division of Biology, who played a pivotal role in the BSI. "So the resources are here, the vision is here, and some of the people are here. Now all we have to do is great science."

Contact: Robert Tindol (626) 395-3631



Subscribe to RSS - BBE